Trial intelligence / Profile preview

RTA 402 Phase 2 Trial in Chronic Kidney Disease with Type 2 Diabetes

jRCT2080222666Phase 2

Sponsor
Kyowa Kirin
Start
Nov 2014
Modality
Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in chronic kidney disease (CKD) and type 2 diabetes mellitus (T2DM) comparing RTA 402 with Placebo (2 arms).

02

Drugs

bardoxolone methyl
03

Conditions

chronic kidney disease (CKD)type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on jRCT2080222666.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080222666.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call